南方医科大学学报
南方醫科大學學報
남방의과대학학보
JOURNAL OF SOUTHERN MEDICAL UNIVERSITY
2014年
7期
988-993
,共6页
王贵佐%张永红%谢新明%韩冬%吴媛媛%李少军%李凤娟%李满祥
王貴佐%張永紅%謝新明%韓鼕%吳媛媛%李少軍%李鳳娟%李滿祥
왕귀좌%장영홍%사신명%한동%오원원%리소군%리봉연%리만상
他汀类药物%感染风险%感染相关死亡率%随机对照实验%荟萃分析
他汀類藥物%感染風險%感染相關死亡率%隨機對照實驗%薈萃分析
타정류약물%감염풍험%감염상관사망솔%수궤대조실험%회췌분석
statins%risk of infection%infection-related mortality%randomized controlled trials%meta-analysis
目的:系统评价他汀类药物能否降低感染的风险及降低感染相关死亡率。方法检索Cochrane图书馆、MEDLINE、EMBASE、PubMed、Elsevier数据库和中国生物医学文献数据库等从建库至2013年9月已完成的有关他汀的随机对照试验(至少100位参与者,持续时间至少4周)。由2位研究者按照纳入标准独立筛选文献、提取资料和评价质量后,应用Stata 12.0软件进行荟萃分析。结果纳入16个随机对照研究,共包括48973例研究对象。荟萃分析结果显示:与安慰剂组比较,他汀类药物能显著降低感染风险(OR=0.93,95%可信区间0.89-0.98,P=0.004)。但是在改善感染相关死亡率方面,两组间无显著性差异(OR=0.96,95%可信区间0.82-1.12,P=0.592)。结论他汀类药物可显著降低感染的风险,但是不能降低感染相关死亡率。
目的:繫統評價他汀類藥物能否降低感染的風險及降低感染相關死亡率。方法檢索Cochrane圖書館、MEDLINE、EMBASE、PubMed、Elsevier數據庫和中國生物醫學文獻數據庫等從建庫至2013年9月已完成的有關他汀的隨機對照試驗(至少100位參與者,持續時間至少4週)。由2位研究者按照納入標準獨立篩選文獻、提取資料和評價質量後,應用Stata 12.0軟件進行薈萃分析。結果納入16箇隨機對照研究,共包括48973例研究對象。薈萃分析結果顯示:與安慰劑組比較,他汀類藥物能顯著降低感染風險(OR=0.93,95%可信區間0.89-0.98,P=0.004)。但是在改善感染相關死亡率方麵,兩組間無顯著性差異(OR=0.96,95%可信區間0.82-1.12,P=0.592)。結論他汀類藥物可顯著降低感染的風險,但是不能降低感染相關死亡率。
목적:계통평개타정류약물능부강저감염적풍험급강저감염상관사망솔。방법검색Cochrane도서관、MEDLINE、EMBASE、PubMed、Elsevier수거고화중국생물의학문헌수거고등종건고지2013년9월이완성적유관타정적수궤대조시험(지소100위삼여자,지속시간지소4주)。유2위연구자안조납입표준독립사선문헌、제취자료화평개질량후,응용Stata 12.0연건진행회췌분석。결과납입16개수궤대조연구,공포괄48973례연구대상。회췌분석결과현시:여안위제조비교,타정류약물능현저강저감염풍험(OR=0.93,95%가신구간0.89-0.98,P=0.004)。단시재개선감염상관사망솔방면,량조간무현저성차이(OR=0.96,95%가신구간0.82-1.12,P=0.592)。결론타정류약물가현저강저감염적풍험,단시불능강저감염상관사망솔。
Objective To systematically review whether statins can reduce the risk of infection and infection-related mortality. Methods We searched the Cochrane Library, MEDLINE, EMBASE, PubMed, Elsevier and CBM databases for randomized placebo-controlled trials of statins published by September 2013, and each trial enrolled at least 100 participants with follow-up for at least 4 weeks. Two reviewers independently assessed the quality of the included studies and extracted the relevant data for analysis using Stata 12.0 software. Results Sixteen trails involving a total of 48973 patients were included in our meta-analysis. The results showed that statins significantly reduced the risk of infection (OR=0.93, 95% CI 0.89 to 0.98, P=0.004) compared to placebo but did not significantly lower infection-related mortality (OR=0.96, 95% CI 0.82 to 1.12, P=0.592). Conclusion Statins can significantly reduce the risk of infection but does not lower infection-related mortality.